Abstract
p53 mutations are the most frequently detected genetic alterations of gliomas, appearing in a similar proportion of low and high grade astrocytomas, while the amplification of epidermal growth factor receptor (EGFR) gene appears mainly in glioblastomas. Thus, these changes seem to delineate two subgroups of high grade astrocytomas: those originating from preexistent low grade astrocytomas and those originating de novo. Paraffin-embedded surgical specimens from 56 human astrocytomas (8 pilocytic (I.) astrocytomas, 9 low grade (II.) fibrillary astrocytomas, 9 high grade (III.) anaplastic astrocytomas and 30 glioblastomas) were analyzed immunohistochemically for the presence of p53 protein and EGFR. Approximately 41% of all cases were p53-protein-positive while 23% were EGFR-positive. Five cases (8.9%) were double-positive for p53 protein and EGFR. The p53-immunopositive nuclei were revealed in 16 cases (53.3%) of glioblastomas, 3 cases (33.3%) of high grade and 4 cases (44.4%) of low grade astrocytomas. None of pilocytic tumors was p53-positive. EGFR immunopositivity increased with the grade of malignancy (11.1%, 22.2% and 33.3%). Double EGFR-p53-positive cases occuried in similar proportions in all grades (approximately 10%) and...Continue Reading
References
Feb 27, 1992·Nature·D SidranskyB Vogelstein
Aug 1, 1992·Journal of Neurosurgery·A von DeimlingO D Wiestler
Jul 1, 1992·Journal of Clinical Pathology·M BarbareschiC Doglioni
Aug 1, 1992·British Journal of Cancer·E JarosA D Pearson
Apr 1, 1992·The Journal of Pathology·D Wynford-Thomas
Jun 6, 1991·Nature·A J LevineC A Finlay
Jun 1, 1989·Journal of Neurosurgery·N AritaH Mogami
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jan 1, 1972·Neurology·A K PercyL T Kurland
May 6, 1984·Nature·A UllrichJ Schlessinger
Nov 1, 1993·The Journal of Pathology·H K HaapasaloJ J Isola
Jan 1, 1994·Acta Neuropathologica·H KogaJ Mukawa
Jan 1, 1993·Brain Pathology·A von DeimlingD N Louis
Jul 1, 1993·Brain Pathology·E W NewcombD C Miller
Jan 15, 1994·Cancer·B S ChozickP W Finch
Jan 1, 1994·Journal of Neuropathology and Experimental Neurology·D N Louis
Jan 1, 1993·Acta Neuropathologica·E KaramitopoulouI Diamantis
Jan 1, 1993·Journal of Neuropathology and Experimental Neurology·D N LouisB R Seizinger
Jan 1, 1993·Acta Neuropathologica·S AlbrechtJ M Bruner
Citations
Jan 15, 1999·Pathology Oncology Research : POR·L SiposB Szende
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Aimee L QuanJohn H Suh
Aug 13, 2013·Neuro-oncology·Fanny Burel-VandenbosThierry Virolle
Oct 11, 2005·Neuro-oncology·Yi-Hong ZhouW K Alfred Yung
Jan 23, 1999·Pathology, Research and Practice·A VitalC Vital
Jul 27, 2006·Neuropathology and Applied Neurobiology·Sally JärveläJ Isola
Apr 17, 2002·Expert Opinion on Biological Therapy·Bela Bodey
Sep 9, 2017·The International Journal of Biological Markers·Fadi S SaadehHazem I Assi
Nov 27, 1999·British Journal of Cancer·X X TianH K Ng
Aug 10, 1999·Cancer·A PerryJ C Buckner
Jul 24, 2010·Journal of Neuro-oncology·Fanny Burel-VandenbosThierry Virolle
Apr 19, 2021·World Neurosurgery·Aleksandra B LasicaGeorge Samandouras
Jan 11, 2000·Archives of Pathology & Laboratory Medicine·T TihanU Moll